Atherectomy Devices Market 2025 – Market Size & Segments Analysis, Industry Trends, Manufacturers Analysis, Opportunities and Forecast 2034

Page: 215 | Report Code: LS250116 | Research Suite: Report (PDF) & Market Data (Excel)

NOTE: Due to exhaustive nature of content, full ToC can't be uploaded. Please request Sample Pages to receive full table of content. 

Atherectomy is a medical procedure that is designed to remove plaque from arteries, found in both coronary and peripheral vascular systems. Plaque accumulation, which causes atherosclerosis, is capable of constricting or blocking blood vessels, resulting in diseases including coronary artery disease (CAD) and peripheral artery disease (PAD). The main purpose of these device is to remove these plaques to restore normal blood flow.

MARKET OVERVIEW

The atherectomy devices market is valued at approximately USD 969.52 million in 2023 and is projected to reach USD 2325.88 million by 2034 exhibiting a compound annual growth rate (CAGR) of 8.28% during the forecast period of 2024-2034. The primary objective of atherectomy devices is to efficiently remove or ablate the plaques while maintaining the structural integrity of the surrounding artery tissue. The devices use various techniques like cutting, shaving, sanding, or vaporizing plaque to restore normal blood flow through the damaged vessels.


GROWTH DRIVERS

The rising prevalence of coronary artery disease and peripheral artery disease is one of the primary factors propelling the market for atherectomy devices. According to the National Institute of Health (NIH), lower extremity peripheral artery disease affected approximately 8.5 million people in the US and around 230 million worldwide in 2021, indicating an increasing demand for efficient treatment solutions. The rising prevalence of these diseases is associated with lifestyle factors including obesity and inactivity, which further increases the requirement for atherectomy procedures.

There is a noticeable shift towards minimally invasive surgeries due to their associated benefits, such as reduced trauma, quicker recovery times, and lower risk of complications compared to traditional open surgery. Atherectomy procedures are acknowledged for their minimally invasive nature, which makes them more appealing to both patients and healthcare providers; thus, driving its market demand.

MARKET SEGMENTATION:

By Type -

·         Directional Atherectomy

·         Rotational Atherectomy

·         Orbital Atherectomy

·         Laser Atherectomy

By Application -

·         Peripheral Vascular Applications

·         Cardiovascular Applications

·         Neurovascular Applications

By End User -

·         Hospitals and Surgical Centers

·         Ambulatory Care Centers

·         Other End Users

By Region -

·         North America

·         Europe

·         Asia Pacific

·         Latin America

·         Middle East & Africa

Atherectomy Devices Market By Type Segment Review:

In directional atherectomy, a catheter with a rotating blade is used to cut away plaque in a specific direction. This technique enables the precise removal of plaque while also preserving the surrounding healthy tissue. The adoption of directional atherectomy in clinical practice is encouraged by the increasing awareness among healthcare professionals about its benefits over traditional methods. The need for efficient treatment alternatives like directed atherectomy are becoming increasingly popular due to the rising incidence of PAD, due to factors such as diabetes, obesity, and an aging population.


Atherectomy Devices Market By Application Segment Review:

The use of atherectomy devices market is becoming increasingly prevalent for peripheral vascular applications, particularly for the treatment of PAD, a common circulatory condition where narrowed arteries reduce blood flow to the limbs. The market for atherectomy devices is substantially expanding due to the rising incidence of peripheral arterial disease. Millions of people worldwide suffer from PAD, which has increased need for efficient treatment solutions. The market growth is further fueled by the aging population's susceptibility to vascular diseases.

Atherectomy Devices Market By End User Segment Review:

Hospitals and surgical centers are primary users of atherectomy devices because of their extensive capabilities in treating cardiovascular disorders. Interventions like atherectomy are necessary to reduce plaque buildup in arteries caused by CVDs, which include peripheral artery disease and coronary artery disease. According to the NIH, CVDs accounted for 20.5 million deaths in 2021 worldwide. The need for efficient treatment options for this expanding patient population is driving up the adoption of atherectomy devices in hospitals and surgical centers.

There is a significant increase in the use of minimally invasive surgical techniques among healthcare providers and patients. This trend is driving hospitals to incorporate atherectomy devices into their standard treatment protocols.

Atherectomy Devices Market By Region Segment Review:

The market exhibits significant regional variations, with North America leading the market in 2024 due to the high prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, and the presence of leading manufacturers in the region.

Atherectomy Devices Market Regional Synopsis:

The market in North America is anticipated to dominate the global market for atherectomy devices market due to high prevalence rates of cardiovascular diseases, favorable reimbursement policies, growing acceptance and adoption of atherectomy systems among medical professionals, and ongoing clinical trials.

Europe is another crucial player in this market, driven by growing geriatric population, rising incidence rates of cardiovascular diseases, and regulatory support.

The Asia Pacific is expected to grow at the highest CAGR during the forecast period due to increasing patient population suffering from cardiovascular conditions, improving healthcare infrastructure, and rising awareness about minimally invasive surgical options among patient and professionals.

In Latin America, the market is gradually expanding due to rising healthcare investments and growing awareness for advanced treatment options for cardiovascular diseases.

The market in the Middle East and Africa is witnessing growth potential due to the increasing prevalence of cardiovascular diseases necessitating advanced treatment options, rising urbanization, and advancement in healthcare infrastructures.


Atherectomy Devices Market Key Challenges:

The high cost associated with this medical equipment is one of the most primary challenges in the market for atherectomy devices. The cost involved in developing, manufacturing, and regulatory approval of atherectomy devices are significant, which often becomes expensive for healthcare providers and patients. For example, cutting-edge technology like lasers and orbital atherectomy devices are usually more costly than traditional methods, which makes them less accessible in certain healthcare settings, especially in developing nations. These gadgets' high cost is likely to hinder its adoption among hospitals and clinics with limited funding or resources.

The regulatory framework for medical devices is becoming increasingly stringent in many regions worldwide. Manufacturers of atherectomy devices are required to navigate complicated approval processes that vary significantly by country, which often delay product launches and increase costs substantially. For instance, for obtaining FDA approval in the United States, it is necessary to undergo rigorous testing and documentation requirements that sometimes take years to complete. The risk and cost associated with these stringent regulations are expected to prevent new entrants from entering the market or discourage innovation among existing players.

Competitive Landscape:

The global market for atherectomy devices is characterized by a diverse range of established players and emerging firms, each striving to enhance their market presence through various strategies such as innovation through technology advancement, strategic partnerships for enhanced product development and distribution channels, strict adherence to regulatory standards, effective communication about minimally invasive benefits, and global expansion efforts.

Companies are investing significantly in research and development (R&D) to innovate and enhance their product offerings. This includes developing more sophisticated devices that improve efficacy and safety. This focus in innovation not only enhances patient outcomes but also boosts the acceptance rate among healthcare professionals.

Key Players:

·         Boston Scientific Corporation

·         Cardiovascular Systems, Inc.

·         Medtronic

·         Avinger

·         Koninklijke Philips N.V.

·         Becton, Dickinson and Company

·         Abbott

·         Cordis

·         Biomerics LLC

·         Terumo Medical Corporation

·         Other Key & Niche Players

Buy Report

  • $1990
  • $2990